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Introduction {#sec1}
============

Asymmetries along the left-right (LR) body axis are a common feature of most animals. Vertebrates, for example, show asymmetric arrangements of most visceral organs ([@bib11]). In all deuterostomes examined, as well as in several protostomes, asymmetries are induced by unilateral activation of the Nodal signaling cascade, consisting of *nodal*, *lefty*, and *pitx2*, before onset of asymmetric organogenesis ([@bib15], [@bib26]). How the Nodal cascade is activated unilaterally is a matter of intense research. The most common symmetry-breaking mechanism in vertebrates is a transient extracellular leftward fluid flow at the archenteron of gastrula/neurula embryos ([@bib5]). Although this flow lost in birds, it is absolutely required for symmetry breakage in rabbit, mouse, frog, and fish ([@bib8], [@bib17], [@bib24]). Flow is generated at the left-right organizer (LRO), a transient ciliated epithelium. Owing to the clockwise rotation of monocilia and their posterior tilting, they generate a leftward flow of extracellular fluids ([@bib4], [@bib40]). Putative LROs have been pinpointed in further vertebrates (axolotl, additional frog species, sturgeon), the ancient chordate amphioxus, and the sea urchin *Paracentrotus* ([@bib5], [@bib21], [@bib33]).

How flow is sensed on the left side of the LRO and how it activates the Nodal cascade in the lateral plate mesoderm (LPM) is still largely unknown. The Nodal inhibitor Dand5 is one decisive factor in chordates. *dand5* and *nodal* are expressed bilaterally on both sides of the LRO, just before flow becomes established. As a result of flow, *dand5* becomes down-regulated on the left ([@bib23], [@bib25]). In *Xenopus*, knockdown of *dand5* rescues flow-deficient embryos, establishing *dand5* mRNA asymmetry as the first detectable molecular feature of LR asymmetry. How this inhibition is realized at the cellular level is not known. One mechanism that has been proposed is a calcium-dependent down-regulation of *dand5* during flow ([@bib41]). Left-sided calcium fluxes during flow stages have been described and implicated in flow sensing, but the molecular consequences have remained elusive ([@bib20], [@bib42]). According to the two-cilia model of symmetry breakage, motile cilia at the center of the LRO create a leftward flow that bends immotile mechanosensory cilia at the left margin. This bending results in left-sided calcium fluxes, which supposedly activate downstream calcium-dependent events that break the bilateral symmetry ([@bib14], [@bib30]). Genetic experiments in the mouse have unequivocally demonstrated that the calcium channel Polycystin-2 is specifically required in lateral cells of the mouse LRO to break symmetry ([@bib41]).

We and others have previously shown that *pkd2*, the gene encoding Polycystin-2, is necessary for kidney and LR development in mouse and for kidney development in *Xenopus*, as it is in other vertebrates ([@bib9], [@bib19], [@bib29], [@bib34]). Here, we revisited the role of Polycystin-2 in LR development in *Xenopus*, in which the sequential steps of laterality development are known in great detail and can be experimentally manipulated in a sided manner. *pkd2* knockdown resulted in failure of Nodal cascade activation, as previously shown for fish and mouse. LRO morphogenesis and function were lost in morphants, as revealed by altered marker gene expression and a lack of ciliation and leftward flow. This phenotype was due to a lack of *pkd2*-dependent induction of the LRO precursor tissue, the superficial mesoderm (SM), during early gastrulation. Polycystin-2 and the FGFR-binding ligand Xnr3 synergize to induce *foxj1* in the SM, establishing an unknown function of Polycystin-2.

Results and Discussion {#sec2}
======================

*pkd2* Is Required for LR Axis Development in *Xenopus* {#sec2.1}
-------------------------------------------------------

As a reference point for the functional assessment of *pkd2* during symmetry breakage, we analyzed mRNA expression during embryogenesis. Signals at the animal pole of the zygote and during early cleavage stages represented maternally deposited transcripts ([Figures 1](#fig1){ref-type="fig"}A and 1B). Sense probe control specimens lacked staining ([Figure 1](#fig1){ref-type="fig"}C; data not shown). During early gastrulation, *pkd2* was restricted to the deep mesoderm, excluding the dorsal lip and the superficial epithelial layer, i.e., the SM, from which the frog LRO, the gastrocoel roof plate (GRP), develops during gastrulation ([Figure 1](#fig1){ref-type="fig"}D; [@bib3]). Later expression sites included the notochord, trunk organizer, deep neuroectoderm, intermediate mesoderm, and developing pronephric kidney ([Figures 1](#fig1){ref-type="fig"}E--1G and [S1](#mmc1){ref-type="supplementary-material"}A--S1E; cf. [@bib34]). Remarkably, zygotic *pkd2* mRNA was not detected in the SM or in the GRP ([Figures 1](#fig1){ref-type="fig"}D and 1G), i.e., the early LR-relevant tissues.Figure 1Expression of *pkd2* mRNA during *Xenopus* Embryogenesis(A--C) Maternally deposited mRNA localized to the animal hemisphere of the zygote (A, A′) and four-cell stage embryos (B). Note animal-vegetal shift of expression as indicated in the zygote. (C) Lack of a specific signal in specimen hybridized with a sense probe.(D--F) *pkd2* transcripts in deep mesodermal layers of the early gastrula (D, D′, D″; black arrowheads; plane of section indicated in D by dotted line), in dorsal notochordal mesoderm at mid gastrula (E), and in tail organizer (white arrow) and posterior notochord at late gastrula stages (F, F′). Please note the lack of transcripts in the dorsal lip and the SM (white arrowheads). Border of inner and outer layer of marginal zone indicated by dotted line. Yolk plug and archenteron roof indicated by dashed lines.(G) Deep neuroectodermal, tail organizer, and posterior notochordal expression at neurula stages; no expression of GRP detected (G~4~).a, anterior; an, animal; ar, archenteron; bf, blastocoel floor; cbc, circumblastoporal collar; dl, dorsal lip; e, endoderm; el, epithelial layer (of cbc); l, left; n, notochord; ne, neuroectoderm; psm, presomitic mesoderm; r, right; s, somites; v, ventral; veg, vegetal; yp, yolk plug.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

In the mouse, Polycystin-2 acts downstream of flow but upstream of flow-dependent *dand5* repression and LPM Nodal induction ([@bib41]). To test whether this function was conserved in *Xenopus*, we targeted a previously characterized antisense morpholino oligomer (MO) that blocks translation of *pkd2* (Pkd2-MO; [@bib34]) to the future GRP (cf. [Figure 2](#fig2){ref-type="fig"}A). Morphant embryos lacked induction of the Nodal cascade in the left LPM in a dose-dependent manner, in agreement with this notion ([Figures 2](#fig2){ref-type="fig"}B--2D). As expected for a flow-sensing function, *pkd2* was required on the left side of the GRP, as revealed by unilateral injections ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B; cf. [@bib35] for left-sided flow knockdown). Knockdown in the LPM itself did not cause LR defects, suggesting that *pkd2* was not relevant for Nodal propagation ([Figure S2](#mmc1){ref-type="supplementary-material"}B). In summary, these results showed that *pkd2* was required for the activation of the Nodal cascade in the left LPM, suggesting a conserved role during flow-dependent symmetry breakage.Figure 2*pkd2* Is Required for LR Asymmetry in *Xenopus*, Independently of *dand5*(A) Putative sensory function of Polycystin-2 during symmetry breakage downstream of GRP-flow.(B--D) Dose-dependent loss of left-sided *pitx2c* expression following Pkd2-MO targeting to the GRP. Black arrowhead indicates approximate location of present or absent *pitx2c* expression on both sides of the embryo. White arrow highlights expression of *pitx2c* around the eye as proof of working ISH.(E) Model of hierarchy of the flow sensing module and possible role of *pkd2* on the lateral side of the LRO downstream of flow and upstream of Dand5.(F) Epistatic single and double knockdown experiments, performed on the left or right side, as indicated. Differences in expected and experimental outcome highlighted by red significance. See text for details.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.\*\*p \< 0.01, \*\*\*p \< 0.001 in all Figures.Numbers in parentheses indicate the number of embryos analyzed for each condition.

*Pkd2* Functions Independently of *dand5* {#sec2.2}
-----------------------------------------

Dand5 plays a key role at the interface between flow and Nodal induction ([Figure 2](#fig2){ref-type="fig"}E). To test whether *pkd2* acted upstream of *dand5* in the process of flow sensing, we performed combinatory knockdown experiments. When Pkd2-MO was injected on the left side of the GRP, embryos failed to induce *pitx2c* in the left LPM, similar to a GRP-specific *nodal1* knockdown. Inhibition of *dand5* alone had no effect, as described ([Figure 2](#fig2){ref-type="fig"}F; cf. [@bib23]), because flow down-regulates *dand5* as a physiological target. When Pkd2-MO and Dand5-MO were co-injected, most specimens still did not induce *pitx2c* ([Figure 2](#fig2){ref-type="fig"}F). *Dand5* knockdown thus failed to rescue loss of Polycystin-2, as was expected from the sensor function described in mouse ([Figure 2](#fig2){ref-type="fig"}E). *Pkd2* therefore could act upstream of *nodal* induction in the LPM. Knockdown of *pkd2* in the LPM, however, did not affect *pitx2* expression ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Alternatively, *pkd2* could be required for *nodal* function at the lateral cells (sensory part) of the GRP. The possibility of sided injections in *Xenopus* afforded the opportunity of investigating this notion on the right side of the GRP, independently of flow. Here, *dand5* knockdown induces right-sided Nodal cascade induction ([Figure 2](#fig2){ref-type="fig"}F; cf. [@bib23]). Parallel knockdown of *dand5* and *nodal1* at the right GRP margin counteracted this effect, as loss of the Nodal inhibitor Dand5 can only be effective in the presence of Nodal. Simultaneous targeting of Dand5-MO and Pkd2-MO to the right GRP margin still prevented right-sided Nodal cascade induction ([Figure 2](#fig2){ref-type="fig"}F), suggesting that *pkd2* was required for Nodal function at the GRP or GRP function in general.

Leftward Flow and GRP Morphogenesis Are Compromised in *pkd2* Morphants {#sec2.3}
-----------------------------------------------------------------------

The high efficiency of Pkd2-MO, comparable with a *nodal1* knockdown in the left GRP, asked for an in-depth analysis of GRP function itself. Leftward flow was analyzed in dorsal explants prepared from flow stage embryos that were injected with control (co-)MO or Pkd2*-*MO as described ([@bib35]). Time-lapse videography of fluorescent beads added to the explants demonstrated that flow was absent at the targeted area in morphants ([Figures 3](#fig3){ref-type="fig"}A, 3C, and [Video S1](#mmc2){ref-type="supplementary-material"}), whereas co-MO injected specimens displayed the previously reported directionality and velocity of bead transport ([Figures 3](#fig3){ref-type="fig"}B and 3D; cf. [@bib24]). This result suggested that GRP function was lost in *pkd2* morphants. A morphological analysis of GRP tissue using immunofluorescence (IF) to highlight cilia and cell boundaries confirmed this notion, as cilia were literally absent ([Figures 3](#fig3){ref-type="fig"}E--3G). To gain further insights into the nature of GRP defects, scanning electron microscopy (SEM) was employed. co-MO-injected specimens ([Figure S3](#mmc1){ref-type="supplementary-material"}A; n = 6) displayed on average 88% ciliated GRP cells, whereas this rate dropped to 34% in *pkd2* morphants, and remaining ciliated cells lacked polarization ([Figure S3](#mmc1){ref-type="supplementary-material"}B; n = 5). Individual specimens lacked cilia altogether. Remarkably, non-ciliated morphant cells revealed an increase in cell surface area and thus resembled endodermal cells rather than the small GRP cells ([Figure S3](#mmc1){ref-type="supplementary-material"}B), indicating a potential change of fate. GRP marker genes, such as the tektin isoform *tekt2* as well as the axonemal dynein motor protein *dnah9*, were absent from morphant explants, whereas control samples exhibited wild-type expression patterns ([Figures 3](#fig3){ref-type="fig"}H--3K, [S3](#mmc1){ref-type="supplementary-material"}C, and S3D). Importantly, GRP ciliation and gene expression were rescued by co-injection of a full-length *pkd2* mRNA construct that was not targeted by the Pkd2-MO ([Figures 3](#fig3){ref-type="fig"}G, 3J, and 3K).Figure 3Leftward Flow and GRP Morphogenesis Are Compromised in *pkd2* Morphants(A--D) Unilateral injection of Pkd2-MO (A) but not co-MO (B) caused disruption of leftward flow at targeted area (red fluorescence: lineage tracer), as revealed by gradient time trail (GTT); see [Transparent Methods](#mmc1){ref-type="supplementary-material"} section and [@bib24] analysis. Quantification of directionality and velocity of bead transport on morphant (C) and control (D) sides of dorsal explants. Rho (r) represents a value for robustness of directionality of leftward flow. Scale bars represent 50 micrometers.(E--G) Stage 17 GRP ciliation (E) was lost in *pkd2* morphants (F) and regained in specimens co-injected with *pkd2*-MO and a full-length *pkd2* mRNA. IF with acetylated α-tubulin antibodies (red) and Alexa 488-phalloidin (green) to highlight GRP cilia and cell borders.(H--K) *tekt2* expression at the GRP of stage 17 dorsal explants (H) was lost in *pkd2* morphants (I) and rescued upon co-injection of a full-length *pkd2* mRNA (J). (K) Quantification of results.(L and M) *nodal1* expression in lateral GRP cells (L) was lost in morphants (M).See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Video S1](#mmc2){ref-type="supplementary-material"}

To investigate the GRP fate in depth, we analyzed marker genes that highlight the lateral sensory cells, namely, *nodal1* and *dand5*. Both were absent from morphant specimens, in which Pkd2-MO was targeted to these cells ([Figures 3](#fig3){ref-type="fig"}L, 3M and [S3](#mmc1){ref-type="supplementary-material"}E--S3H). A further SEM analysis revealed that lateral GRP cells were missing completely and that remaining ciliated central GRP cells directly bordered non-ciliated endodermal cells ([Figure S3](#mmc1){ref-type="supplementary-material"}I). In the absence of *nodal1*, the Dand5-MO thus remained without effect, providing a stringent explanation for the nearly complete lack of *pitx2c* induction upon *dand5* knockdown in *pkd2* morphants (cf. [Figure 2](#fig2){ref-type="fig"}F).

Polycystin-2 is mainly part of a cilia- or endoplasmic reticulum (ER)-located calcium channel complex, which can modulate cellular calcium levels, and itself can be regulated by intracellular calcium ([@bib6]). To test if manipulations of intracellular calcium levels also affected *nodal1* expression, we treated embryos with Thapsigargin (Tg), a well-known antagonist of ER-located SERCA pumps ([@bib32]). Embryos treated at early gastrulation showed blastopore closure defects, caused by lack of necessary intracellular calcium waves, as previously reported ([@bib37]; data not shown). Treatment from late gastrula stages onward, however, did not affect gastrulation and resulted in reduced or absent *nodal1* expression at neurula stages, i.e., when *nodal1* is initiated in lateral GRP cells before flow occurs ([Figures S3](#mmc1){ref-type="supplementary-material"}J--S3L). This outcome was supported by another set of experiments. When embryos were treated in the same way with BAPTA-AM, an intracellular calcium chelator, they also showed reduced expression of *nodal1* at neurula stages ([Figures S3](#mmc1){ref-type="supplementary-material"}M--S3P). These results support the notion that Polycystin-2 is necessary to induce the lateral cell fate of the LRO in *Xenopus*, and this required intracellular calcium changes. Yet, these findings were unexpected, as altered LRO *nodal* expression was not reported from *pkd2*-knockout mice or zebrafish morphants ([@bib2], [@bib19]). Mouse embryos treated with Tg, however, showed loss of *nodal1* in the LRO and LPM as well, arguing for conservation of a calcium-dependent induction of lateral LRO fates ([@bib31]). Taken together, these analyses demonstrated that LR defects in *Pkd2* morphants were caused by impaired GRP morphogenesis and function and, specifically, the absence of lateral LRO cells expressing *nodal1* and *dand5*.

*pkd2* Is Required for SM Specification {#sec2.4}
---------------------------------------

Next, we asked whether the GRP precursor tissue, the SM, was correctly specified during gastrulation. To that end, we analyzed SM marker genes *xnr3* and *foxj1*. Both genes are known targets of canonical Wnt signaling; *foxj1* is instrumental for SM and GRP function downstream of Wnt signaling ([@bib10], [@bib27], [@bib28], [@bib36]). Remarkably, these genes responded differently to *pkd2* knockdown: *xnr3* was slightly upregulated, whereas *foxj1* expression was reduced or absent ([Figures 4](#fig4){ref-type="fig"}A--4F). This effect was specific, as *foxj1* expression was rescued (or even super-induced) upon co-injection of full-length *pkd2* mRNA ([Figures 4](#fig4){ref-type="fig"}F and [S4](#mmc1){ref-type="supplementary-material"}A--S4C). As reported, calcium spikes during gastrulation were dependent on intracellular calcium ([@bib37]), and we treated embryos again with Tg. To test whether *foxj1* expression was dependent on calcium dynamics as well, specimens were treated with brief pulses (maximum 20 min) at stage 9, when *foxj1* expression is initiated before the start of gastrulation. Treated embryos developed without gastrulation defects but showed a lack of *pitx2c* expression in more than 60% of cases, reminiscent of *pkd2* morphants ([Figures S4](#mmc1){ref-type="supplementary-material"}D--S4F). When such specimens were analyzed at the onset of gastrulation (st. 10.5), *foxj1* was reduced or absent as well, confirming a requirement of both calcium-dependent signals and Polycystin-2 for *foxj1* induction ([Figures 4](#fig4){ref-type="fig"}G--4I). Surprisingly, in our hands, similar incubations during the initiation of *foxj1* expression (late blastula st. 9 until early gastrula st. 10.5) using the calcium-chelator BAPTA-AM did not alter *foxj1* expression ([Figures S4](#mmc1){ref-type="supplementary-material"}G--S4I). Accordingly, such treated embryos did not show LR axis alterations at tail bud stages, as shown by wild-type *pitx2c* expression ([Figure S4](#mmc1){ref-type="supplementary-material"}J). However, embryos incubated in BAPTA-AM from late blastula (st. 9) to late gastrula stages (st. 12.5), i.e., additionally covering the later sensitive time window of *nodal1* initiation in the lateral GRP (cf. [Figures S3](#mmc1){ref-type="supplementary-material"}J--S3P), again developed laterality defects by misexpression of *pitx2c* ([Figure S4](#mmc1){ref-type="supplementary-material"}J). These results suggested that Polycystin-2/Tg and BAPTA-AM have different effects on the process of *foxj1* induction. Yet, in sum, these experiments are in line with a function for *pkd2* and specific calcium changes in the specification of the SM as the LRO precursor tissue.Figure 4Polycystin-2 and Xnr3 Synergize to Induce the LRO Precursor Tissue of the Superficial Mesoderm(A--F) Increased *xnr3* (A--C) and reduced *foxj1* expression (D--F) in stage 10.5 *pkd2* morphants (B and E) as compared with control specimens (A and D). Dotted lines in A and B indicate plane of histological sections shown in A′, and B′, respectively. Note that *foxj1* expression was rescued upon co-injection of a full-length *pkd2* mRNA (F).(G--I) Reduced *foxj1* expression in early gastrula stages (st. 10.5) following Tg treatment (G, DMSO control embryo; H, Tg treated specimen; I, quantification of results).(J--S) *xnr3* and *pkd2* synergize SM *foxj1* induction. Loss of *xnr3* resulted in attenuated *foxj1* expression (K and O) compared with control uninjected specimens (J and O), which was highly efficiently rescued by co-injection of full-length *xnr3* mRNA (L and O). Both dorsal (M) and ventral (N) overexpression of *xnr3* mRNA caused an increase of endogenous or induction of ectopic *foxj1*, respectively (M--O). Injections of reduced MO doses of Xnr3-MO (O, R; 2 × 0.6pmol) or Pkd2-MO (O, Q; 2 × 0.75pmol) caused mild reductions of *foxj1* expression. Co-injection of low doses of MOs resulted in strong inhibitory effects (O and S).(T) Schematic depiction of known (black) and proposed (green) interactions required for SM specification. For details refer to main text. Increase of expression highlighted with white arrowheads and decrease with black arrowheads. Numbers in parentheses indicate the number of embryos analyzed for each condition.See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

*pkd2* Synergizes with *xnr3* to Induce *foxj1* in the Superficial Mesoderm {#sec2.5}
---------------------------------------------------------------------------

Little is known about early signaling pathways that set up the SM. We and others previously demonstrated that canonical Wnt signaling, which depends on type 3 serotonin receptor signaling (Htr3) in the SM, was required for the induction of both *xnr3* and *foxj1* ([@bib1]). In that light, the above-mentioned up-regulation of *xnr3* in *pkd2* morphants ([Figures 4](#fig4){ref-type="fig"}A--4C) argued against the participation of Polycystin-2 as part of the Wnt signaling module upstream of *xnr3* and *foxj1*. To verify this, we analyzed whether *pkd2* was required for Wnt-dependent secondary axis induction. Twinning was induced by ventral injection of *wnt8* mRNA, in the presence or absence of Pkd2-MO. Inhibition of Polycystin-2 did not affect the frequency of secondary axis formation ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5C), nor did it affect endogenous organizer gene expression (not shown). Polycystin-2, thus, should not be part of upstream canonical Wnt signaling but control *foxj1* induction in the SM independently.

The opposing effects of *pkd2* knockdown on *foxj1* and *xnr3* made us wonder whether the effect on *foxj1* was mediated through Xnr3. This nodal-related gene is unusual, as it does not interact with TGF-β-type receptors but interacts with Fgf receptor 1 (Fgfr1); MO-mediated *xnr3* knockdown specifically inhibits *brachyury* expression ([@bib39]). Besides serving as an SM marker gene, this *Xenopus*-specific factor has not been investigated for a possible function in the context of LR asymmetry. To test whether Xnr3 played a role in laterality determination, we targeted the Xnr3-MO to the dorsal midline (organizer and SM). Knockdown resulted in loss of dorsal *brachyury* expression, as described previously ([Figures S5](#mmc1){ref-type="supplementary-material"}D--S5F; [@bib39]). Strikingly, when such specimens were analyzed for *foxj1*, expression in the SM was also lost or strongly reduced as compared with control embryos ([Figures 4](#fig4){ref-type="fig"}J, 4K, and 4O). This phenotype was specific to loss of Xnr3 function, as reintroduction of full-length *xnr3*-mRNA, which is insensitive to the Xnr3-MO, was able to rescue the observed reduction of *foxj1* very efficiently ([Figures 4](#fig4){ref-type="fig"}L and 4O). Morphants that were raised further revealed the previously reported convergent extension defects ([@bib39]) and altered *pitx2c* expression (data not shown).

Conversely, when *xnr3* was overexpressed in the dorsal SM, an increase of *foxj1* expression was observed, specifically in the more lateral part of the expression domain, the future lateral GRP, demonstrating that Xnr3 was able to enhance *foxj1* expression ([Figures 4](#fig4){ref-type="fig"}M and 4O). Interestingly, injecting *xnr3* mRNA into the ventral side was sufficient to induce *foxj1* expression ectopically, demonstrating its role in SM fate specification ([Figures 4](#fig4){ref-type="fig"}N and 4O). This could indicate a potential role of the well-characterized ventral Bmp signaling pathway in preventing the activation of *foxj1* in the ventral superficial layer, as it has been shown that Xnr3 itself has a dorsalizing effect by inhibiting Bmp signaling ([@bib12], [@bib13]). Thus, to finally test whether *xnr3* and *pkd2* synergized in SM *foxj1* induction, we performed epistasis experiments. MO doses for both genes were reduced such that individually they did not result in a strong reduction of *foxj1* expression. Combined injection of Pkd2-MO and Xnr3-MO, however, resulted in a strong reduction or loss of *foxj1*, establishing a genetic interaction of these genes in SM *foxj1* induction and, thus, in setting up a functional LRO ([Figures 4](#fig4){ref-type="fig"}O--4S). Interestingly, although exogenously introduced *pkd2* mRNA caused an increase of *foxj1* expression ([Figure S4](#mmc1){ref-type="supplementary-material"}C), it was not sufficient to rescue *foxj1* expression in *xnr3* morphant specimens (data not shown).

In summary, our data demonstrate that in general terms, *pkd2* is a conserved determinant of LR symmetry breakage in *Xenopus*. Surprisingly, however, *pkd2* is strictly required upstream of leftward flow to set up the LRO during gastrulation, together with *xnr3* ([Figure 4](#fig4){ref-type="fig"}T). Polycystin2 in the future SM cells could provide a crucial signal for specification. However, the protein of such cell-autonomous function should be of maternal origin, particularly because zygotic mRNA was not detected in the LR-relevant tissues, SM and GRP. Alternatively, Pkd2 could act non-cell autonomously in the deep tissue to induce *foxj1* in the superficial layer, i.e., indirectly. It remains to be seen which type of activating signal could mediate this induction. Based on our timed Tg treatments at the blastula or late gastrula stages ([Figures 4](#fig4){ref-type="fig"}G--4I and [S3](#mmc1){ref-type="supplementary-material"}J--S3L), and the corresponding central or lateral Pkd2-MO injections ([Figures 3](#fig3){ref-type="fig"}M and [4](#fig4){ref-type="fig"}E, respectively), which resulted in either loss of *foxj1* or loss of *nodal1*, respectively, the following conclusion can be drawn. These differentiable results from two different time points of LR symmetry breakage imply that both Pkd2 function and intracellular calcium changes are necessary at two separate steps of LRO induction and sub-functionalization in *Xenopus* ([Figure 4](#fig4){ref-type="fig"}T). It remains to be seen which other signaling pathways could be required for each of these steps.

In any way, we propose that in evolutionary terms, this may represent an ancestral Polycystin-2 function in amphibian embryos, which undergo a basal mode of vertebrate gastrulation and thus LRO development ([@bib5], [@bib7]). Interestingly, zebrafish morphant but not mutant embryos display early mesendodermal defects after maternal *pkd2* knockdown, reminiscent of SM loss in *Xenopus* ([@bib22]). It is tempting to speculate that Fgf signaling represents the common denominator in this context, as Xnr3 binds and signals via the Fgfr1 ([@bib39]). In zebrafish, Fgfr1 signaling affects *foxj1* expression, LRO ciliogenesis, and flow ([@bib16]). In mouse embryos, early loss of Fgfr1-mediated signaling results in gastrulation defects, but *pkd2*-knockout mice do not display impaired LRO formation or flow ([@bib38], [@bib41]). Treatment with an Fgfr1 inhibitor, however, blocked *nodal* expression in lateral LRO cells ([@bib18]) in much the same way as observed upon loss of *pkd2* in *Xenopus*. Thus, LRO induction, although still dependent on Fgfr1, may have become independent of (maternal) *pkd2* in modern bony fish and mammals. The later role of Polycystin-2 in flow sensing at the lateral LRO cells may very well be conserved in amphibians as well. The loss of LRO and flow in *pkd2* morphants precluded the analysis in the context of the present study. The novel role ascribed to Polycystin-2 in Xnr3-/FGF-dependent LRO morphogenesis adds to the long list of functions of this factor that is conserved in animals from nematodes to humans.

Methods {#sec3}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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